Evaluation of pulmonary toxicities in lymphoma patients receiving brentuximab vedotinTiffany Guan, Bita Fakhri, Raymond Chu et al.|Leukemia & lymphoma/Leukemia and lymphoma|2022Cited by 5
Evaluation of Pulmonary Toxicities in Lymphoma Patients Receiving Brentuximab VedotinTiffany Guan, Bita Fakhri, Mimi Lo et al.|Blood|2021Cited by 1
Pembrolizumab + GVD with ctdna-guided consolidation for relapsed/refractory classic Hodgkin lymphoma: A multicenter phase 2 Study of the University of California hematologic malignancies consortiumMichael P. Randall, Michael A. Spinner, David M. Kurtz et al.|Blood|2025Cited by 1